Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis
Clinical trial NCT00566618 · COMPLETED
Trial details
- NCT number
- NCT00566618
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2020-11-17
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.